be visible on the BioBusiness market ISSN 2300-0228

Log in | Register

Pivotal announces participation in two clinical trials with a novel investigational immunotherapy drug to treat melanoma and lung cancer
Impressions from the visit to Wageningen, the specter of famine, CRISPR Cas9 to the rescue!
Reach out to potential partners and customers in the Danish-Swedish life science cluster, Medicon Valley
Central European Healthcare Expo (20-21.05.2020 Global Expo Warsaw)
The world of healthcare ...

All articles

Filters:

Show search box

2015-11-16

Movember – about a microbiome in (prostate) cancer risk

Movember – about a microbiome in (prostate) cancer risk

10 years ago a Nobel Prize awarded a discovery connecting Helycobacter pylori with gastric carcinogenesis. But only today, a host-microbiome relation research starts to enter its critical phase. It turns out, that we are not the only architects of our own fortune – they are, small frequenters of our ... Read more

Tags cancer , movember , prostate cancer , microbiome , microflora , cancer risk , holobiont